@article{CCO22037,
author = {Michael Pazianas and Bo Abrahamsen},
title = {Does bisphosphonate treatment reduce the risk of future cancer?},
journal = {Chinese Clinical Oncology},
volume = {8},
number = {Suppl 1},
year = {2018},
keywords = {},
abstract = {Bisphosphonates are the first line of treatment for osteoporosis and metastatic bone cancer. It is almost fifty years since their antiresorptive properties were described and subsequently were used clinically.},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/22037}
}